Forum Topic News
  • Conversation: Cancer Research UK announces drug discovery collaboration with Celgene Corporation

    • December 15, 2017 12:29 PM GMT
      • Post(s)

      Cancer Research UK announces drug discovery collaboration with Celgene Corporation

      (Friday) - Cancer Research UK today announced the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology (CRT), and Celgene Corporation (link is external), to discover, develop and commercialise new anti-cancer treatments.
      This arrangement represents an expansion of Cancer Research Technology’s theme-based translational model that now encompasses six industry partnerships, including this new collaboration with Celgene.
      The collaboration is centred on mRNA translation, the cellular process of assembling proteins, which is a promising area of research with the potential to produce treatments that can target a fundamental characteristic of cancer cells.
      Dr Iain Foulkes, Cancer Research Technology’s CEO, said: “This bold and exciting collaboration between one of industry’s leading innovators, Celgene, and CRT is part of our theme-based drug discovery approach and helps leverage our understanding of cancer biology and the needs of patients to drive the most promising discoveries into the clinic.
      “This is our largest drug discovery collaboration to date and represents a major endorsement of the reputation and scale of our capacity and expertise in both drug discovery and clinical development by a leading industry partner.”
      Cancer Research Technology will lead drug discovery R&D activity and can progress clinical candidates through phase one trials.
      Read more:

Add Reputation

Do you want to add reputation for this member by this post?

or cancel